Theory and practice in the management of depressive disorders

International Clinical Psychopharmacology

Volumn 14, Issue SUPPL. 3, 1999, Pages

  Linden, Michael ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Antidepressants; Pharmacoepidemiology; Phase IV research; Primary care psychiatry; Quality of care; Treatment guidelines

Indexed keywords

ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CONFERENCE PAPER; DEPRESSION; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HUMAN; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MEDICAL RESEARCH; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOTHERAPY;

DEPRESSIVE DISORDER; EVIDENCE-BASED MEDICINE; HUMANS; TREATMENT OUTCOME;

EID: 0032766513     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199906003-00004     Document Type: Conference Paper

References (89)

1. Agency for Health Care Policy and Research: Depression in Primary Care (1993). Clinical Practice Guidelines, Number 5. Rockville: U.S. Department of Health and Human Services, Public Health Service, AHCPR Pub. No. 93-0551
2. APA (1993). Practice guidelines for major depressive disorder in adults. Am J Psyschiatry 150:1-26.
3. Arzneimittelkommission der Deutschen Ärzteschaft (1997). Empfehlungen zur Therapie der Depression. Arzneiverordnung in der Praxis, Sonderheft 8.
4. Badger LW, DcGruy FV, Hartman J, Plant MA, Leeper J, Anderson R, et al. (1994). Patient presentation, interview content, and the detection of depression by primary care physicians. Psychosom Med 56:128-135.
5. Basco MR, Rush AJ (1995). Compliance with pharmacotherapy in mood disorders. Psychiatr Ann 25:269-279.
6. Bauer M, Berghöfer A (1997). Therapieresistente Depressionen. Berlin: Springer
7. Beardon PHG, McGilchrist MM, McKendrick AD, McDevitt DG, McDonald TM (1993). Primary non-compliance with prescribed medication in primary care. BMJ 307:846-848.
8. Bellantuono C, Fiorio R, Williams P, Arreghini E, Carson G (1988). Urban-rural differences in psychotropic drug prescribing in northern Italy. Eur Arch Psychiatry Neurol Sci 237:347-350.
9. Brunello N, Langer SZ, Perez J, Racagni G (1995). Current understanding of the mechanism of action of classic and newer antidepresant drugs. Depression 2:119-126.
10. Buckalew LW (1991). Patient's compliance: the problem and directions for psychological research. Psychol Rep 68:348-350.
11. Callahan CM, Hendrie HC, Dittus RS, Brater DC, Hui SL, Tierney WM (1994). Improving treatment of late life depression in primary care: a randomized clinical trial. Am Geriat Soc 42:839-846.
12. Connelly JE, Philbrick JT, Smith GR, Kaiser DL, Wymer A (1989). Health perceptions of primary care patients and the influence on health care utilization. Med Care 27:99-109.
13. Coryell W, Endicott J, Keller M (1990). Outcome of patients with chronic affective disorder: a five-year follow-up. Am J Psychiat 147:1627-1633.
14. Coyne JC, Schwenk TL, Fechner Bates S (1995). Nondetection of depression by primary care physicians reconsidered. Gen Hosp Psychiat 17:3-12.
15. Doerner D (1985). Verhalten, Denken und Emotionen. In: Emotion und Reflexivität. Eckensberger E, Lantermann D (editors). München: Urban u. Schwarzenberg.
16. Donoghue JM, Tylee A (1996). Prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatry 168:164-168.
17. Frank E, Karp JF, Rush AJ (1993). Efficacy of treatments for major depression. Psychopharmacol Bull 29:457-475.
18. Gaebel W (1995). Qualitätssicherung im psychiatrischen Krankenhaus. Wien: Springer.
19. Goldberg D (1979). Detection and assessment of emotional disorders in a primary care setting. Int J Ment Health 8:30-48.
20. Goldberg D (1990). Reasons for misdiagnosis. In: Psychological Disorders in General Medical Settings. Sartorius N, Goldberg D, De Girolamo G, Caosta e Silva J, Lecrubier Y, Wittchen U (editors). Toronto: Hogrefe and Huber.
21. Good MJD, Good BJ, Cleary PD (1987). Do patient attitudes influence physician recognition of psychosocial problems in primary care? J Fam Pract 25:53-59.
22. Goodwin GM, Nolen WA (1997). Treatment of bipolar depressive mood disorders: algorithms for pharmacotherapy. Int J Psychiat Clin Prac 1:9-12.
23. Gothe H, Linden M (1997). Das Problem des vorzeitigen Therapieabbruchs. Psychopharmakotherapie 4:36-39.
24. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER (1993). The economic burden of depression in 1990. J Clin Psychiat 54:405-418.
25. Haynes RB, Taylor DW, Sackett DL (1979). Compliance in Health Care. Baltimore: Johns Hopkins University Press.
26. Helmchen H, Baltes MM, Geiselmann B, Kanowski S, Linden M, Reischies FM, et al. (1999). Psychiatric illnesses in old age. In: The Berlin Aging Study. Aging from 70 to 100. Baltes PB, Mayer HU (editors). Cambridge: Cambridge University Press.
27. Hirschfeld RM, Keller MB, Panico S, Arons BS, Barlow D, Davidoff F, et al. (1997). The National Depressive and Manic-Depressive Association Consensus Statement on the Undertreatment of Depression. JAMA 277:333-342.
28. Hoeper EW, Nycz GR, Kessler L, Burke J, Pierce W (1984). The usefulness of screening for mental illness. Lancet i:33-35.
29. Hohmann AA (1989). Gender bias in psychotropic drug prescribing in primary care. Med Care 27:478-490.
30. Hollon SD, Shelton RC, Loosen PT (1991). Cognitive therapy and pharmacotherapy for depression. J Consult Clin Psychol 59:88-99.
31. Huszonek JJ, Dewan MJ, Koss M, Hardoby W, Ispahani A (1993). Antidepressant side-effects and physician prescribing patterns. Ann Clin Psychiatry 5:7-11.
32. Eisenberg L (1988). Science in medicine: too much or too little and too limited in scope? Am J Med 84:483-491.
33. Imber SD, Pilkonis PA, Sotsky SM, Elkin I, Watkins JT, Collins JF, et al. (1990). Mode-specific effects among three treatments for depression. J Consult Clin Psychol 58:352-359.
34. Judd LL (1995). Mood disorders in the general population represent an important and worldwide public health problem, Int Clin Psychopharmacol 4:5-10
35. Kasper S, Lepine JP, Mendlewicz J, Montgomery SA, Rush AJ (1995). Efficacy, safety, and indications for tricyclic and newer antidepressants. Depression 2:127-137
36. Kasper S (1997). Treatment of unipolar major depression: algorithms for pharmacotherapy. Int J Psychiat Clin Pract 1:5-7.
37. Katon W, Robinson P, Von Korff M, Lin E, Bush T, Ludman E, et al. (1996). A Multifaceted Intervention to Improve Treatment of Depression in Primary Care. Arch Gen Psychiatry 53:924-932.
38. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 51:8-19.
39. Kirmayer LJ (1988). Mind and body as metaphors: hidden values in biomedicine. In: Biomedicine examined. Lock M, Gordon G (editors). Dordrecht: Kluwer Academic. pp. 57-93.
40. Khunli K, Baker R, Robertson N (1998). Development of evidence-based review critewria for the management of patients with depression in primary care. Primary Care Psychiatry 4:29-33.
41. Langwieler G, Linden M (1993). Therapist individuality in the diagnosis and treatment of depression. J Affect Dis 27:1-12.
42. Levine J (ed) (1979). Coordinating clinical trials in psychopharmacology: planning, documentation, and analysis. DHEW Publication No (ADM) 79-803. Washington: US Government Printing Office,
43. Linden M (1988). Die Bedeutung der Zeit für die Therapie depressiver Syndrome in der ambulanten Praxis. In: Aktuelle Aspekte der Psychiatrie in Klinik und Praxis. Hippius H, Schmauss M (editors). München: Zuckschwerdt,
44. Linden M (1993). Postmarketing surveillance of psychotherapeutic medications: a challenge for the 1990s. Psychopharmacol Bull 29:51-56
45. Linden M (1994). Therapeutic standards in psychopharmacology and medical decision-making. Pharmacopsychiatry 27:41-45.
46. Linden M (1996). Cognitive-behaviour therapy under conditions of routine treatment in the general health care system. Behav Cogn Psychother 24:39-50.
47. Linden M (1997). The role of the patient in treatment decisions. Mood disorders. Systematic medication management. Mod Prob Pharmacopsychiat 25:192-202.
48. Linden M (1998). Counseling by psychiatrists and general practitioners additional to the prescription of an antidepressant drug. Paper presented at the conference of the German Association of Psychiatrists, Essen, Germany.
49. Linden M, Schüssler G (1985). Low dosage antidepressant treatment in private psychiatric practice. A replication study. Pharmacopsychiatry 18:44-45.
50. Linden M, Osterheider M, Nickelsen T, Schaaf B (1993). Three types of early termination of antidepressant drug treatment. Int Clin Psychopharmacol 8:345-346.
51. Linden M, Helmchen H, Mackert A, Müller-Oerlinghausen B (1994). Structure and feasibility of a standardized stepwise drug treatment regimen (SSTR) for depressed patients. Pharmacopsychiatry 27:51-53.
52. Linden M, Borchelt M, Barnow S, Geiselmann B (1995). The impact of somatic morbidity on the Hamilton Depression Rating Scale in the very old. Acta Psychiat Scand 92:150-154.
53. Linden M, Kurtz G, Baltes MM, Geiselmann B, Lang FR, Reischies FM, Helmehen (1998). Depression bei Hochbetagten. Ergebnisse der Berliner Altersstudie. Nervenarzt 69:27-37.
54. Linden M, Lecrubier Y, Bellantuono C, Benkert O, Kisely S, Simon G (1999). Psychotropic drug precribing by primary care physician: An international collaborative study. Int J Clin Psychopharmacol 19:132-140.
55. Lloyd C (1980). Life events and depressive disorder reviewed. Arch Gen Psychiat 37:541-548.
56. Lloyd KR, Moodley P (1992). Psychotropic medication and ethnicity: An inpatient survey. Soc Psychiat Epidemiol 27:95-101.
57. MacDonald TM, McMahon AD, Reid GW, Fenton GW, et al. (1996). Antidepressant drug use in primary care: A record linkage study in Tayside, Scotland. BMJ 313:860-861.
58. Maslowski J (1987). Characteristic differences in the use of psychotropic drugs as a stigma of cultural influences. Bull Inst Marit Trop Med Gdynia 38:133-138.
59. Meredith LS, Wells KB, Kaplan SH, Mazel RM (1996). Counseling typically provided for depression: Role of clinical specialty and payment system. Arch Gen Psychiatry 53:905-912.
60. Mishler EG (1984). The discourse of medicine: dialectics of medical interviews. Norwood: Ablex Publishing.
61. Morabia A, Fabre J, Dunand JF (1992). The influence of patient and physician gender on prescription of psychotropic drugs. J Clin Epidemiol 45:111-116.
62. Munizza C, Tibaldi G, Bollini P, Pirfo E, Punzo F, Gramaglia F (1995). Prescription pattern of antidepressants in outpatient psychiatric practice. Psychol Med 25:771-778.
63. Olfson M, Weissman MM, Leon AC, Higgins ES, Barrett JE, Blacklow RS (1995). Psychological management by family physicians. J Fam Pract 41:543-550.
64. Ormel J, van den Brink W, Koeter MW, Giel R, van den Meer K, van de Willige G, Wilmink FW (1990). Recognition, management and outcome of psychological disorders in primary care: a naturalistic follow-up study. Psychol Med 20:903-923.
65. Ormel J, Giel R (1990). Medical effects of nonrecognition of affective disorders in primary care. In: Psychological Disorders in General Medical Settings. Sartorius N, Goldberg D, De Girolamo G, Caosta E, Silva J, Lecrubier Y, Wittchen U (editors). Toronto: Hogrefe and Huber.
66. Paykel PJ, Priest RG (1992). Recognition and managemnent of depression in general practice: consensus statement. BMJ 305:1198-1202.
67. Perry PJ, Zeilmann C, Arndt S (1994). Tricyclic antidepressant concentration in plasma: an estimate of their sensitivity an specificity as a predictor of response. J Clin Psychopharmacol 14:230-240.
68. Prien RF, Kupfer DJ (1986). Continuation drug therapy for major depressive episodes: how long should it be maintained? Am J Psychiatry 143:18-23.
69. Raynes NV (1979). Factors affecting the prescribing of psychotropic drugs in general practice consultations. Psychol Med 9:671-679.
70. Ried LD, Christensen DB (1988). A psychosocial perspective in the explanation of patient's drug-taking behavior. Soc Sci Med 27:277-285.
71. Roberts AG, Montgomery SA (1995). Antidepressants in the propylactic treatment of recurrent major depression. Depression 2:145-151.
72. Rush AJ (1977). Mood disorders. Systematic medication management. Basel: Karger.
73. Rush AJ, Prien RF (1995). From scientific knowledge to the clinical practice of psychopharmacology: can the gap be bridged? Psychopharmacol Bull 31:7-20.
74. Rutz W, Knorring von L, Walinder J (1992). Long-term effects of an educational programme for general practitioners given by the Swedish Committee for the Prevention and Treatment of Depression. Acta Psychiat Scand 85:83-88.
75. Sackett DL, Rosenberg WMC, Gray GH, Haynes RB, Richards WS (1996). Evidence-based medicine. What it is and what it isn't. BMJ 312:71-73
76. Schulberg HC, Burns BJ (1988). Mental disorders in primary care: epidemiologic, diagnostic, and treatment research directions. Gen Hosp Psychiatry 10:79-87.
77. Schulberg HC, Block MR, Madonia MJ, Scott CP, Rodriguez E, Imber SD, et al. (1996). Treating major depression in primary care practice. Eight-month clinical outcomes. Arch Gen Psychiatry 53:913-919.
78. Schulberg HC, Block MR, Madonia MJ, Scott CP, Rodrguez E, Imber SD, et al. (1996). Treating major depression in primary care practice: Eight-month clinical outcomes. Arch Gen Psychiatry 53:913-919.
79. Sherbourne CD, Wells KB, Hays RD, Rogers W, Burnam MA, Judd LL (1994). Subthreshold depression and depressive disorder: clinical characteristics of general medical and mental health specialty outpatients. Am J Psychiatry 151:1777-1784.
80. Tiemens BG, Ormel J, Simon GE (1996). Occurrence, recognition, and outcome of psychological disorders in primary care. Am J Psychiatry 153:636-644.
81. Üstün TB, Sartorius N (1995). Mental Illness in General Health Care. Chichester: Wiley.
82. Vogel G, Schulte D (1991). Der Prozeß therapeutischer Entscheidungen. In: Therapeutische Entscheidungen. Schulte D (editor). Göttingen: Hogrefe.
83. Von Korff M, Shapiro S, Burke JD, Teitelbaum M, Skinner EA, German P, et al. (1987). Anxiety und depression in a primary care clinic: comparison of Diagnostic Interview Schedule, General Health Questionnaire and practitioner assessment. Arch Gen Psychiatry 44:152-156.
84. Wells K, Stewart A, Hays R et al. (1989). The functioning and well-being of depressed patients: results from the Medical Outcome Study. JAMA 262:914-919.
85. Wessling A, Bergman U, Westerholm B (1991). On the differences in psychotropic drug use between the three major urban areas in Sweden. Eur J Clin Pharmacol 40:495-500.
86. WHO (1991). Quality assurance in mental health. Geneva: Division of Mental Health, WHO.
87. WHO (1992). International Statistical Classification of Diseases and Related Health Problems. 10th rev. Geneva: WHO.
88. Williams P (1983). Factors influencing the duration of treatment with psychotropic drugs in general practice: a survival analysis approach. Psychol Med 13:45-55.
89. World Psychiatric Association and International Committee for Prevention and Treatment of Depression (1996). Educational Programme on Depressive Disorders. WPA Materials.